Skip to content

Effects of Esketamine Combined with Liposomal Bupivacaine in Thoracic Paravertebral Nerve Block or Intercostal Nerve Block on Chronic Postoperative Pain in Adult Women Undergoing Radical Resection for Lung Cancer: A Randomized Controlled Factorial Study

Effects of Esketamine Combined with Liposomal Bupivacaine in Thoracic Paravertebral Nerve Block or Intercostal Nerve Block on Chronic Postoperative Pain in Adult Women Undergoing Radical Resection for Lung Cancer: A Randomized Controlled Factorial Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123112
Enrollment
Unknown
Registered
2026-04-21
Start date
2026-04-21
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic postoperative pain

Interventions

Experimental Group 4 (PI Group):Intravenous injection of the same amount of normal saline (placebo) + intercostal nerve block
Experimental Group 3 (PT Group):Intravenous injection of the same amount of normal saline (placebo) + paravertebral nerve block
Experimental Group 1 (ET Group):Intravenous injection of esketamine + paravertebral nerve block
Experimental Group 2 (EI Group):Intravenous injection of esketamine + intercostal nerve block

Sponsors

Henan Provincial People's Hospita,medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients scheduled for radical lung cancer surgery; 2.The anesthesia method used was general anesthesia; 3.The operation lasted for more than one hour; 4.Age range: 18 - 80 years old; 5.ASA classification grades I - III; 6.Voluntary signing of the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Those who received radiotherapy or chemotherapy during the perioperative period; 2.Previous history of chest surgery; 3.Allergic reactions to the drugs used in this study; 4.Alcohol abuse, long-term use of opioid drugs or other painkillers; 5.History of opioid and analgesic drug use 3 months prior to the surgery; 6.Patients who had chronic pain before the operation; 7.BMI >=35kg/m^2; 8.Those with severe diseases of the heart and blood vessels; 9.Those with severe liver and kidney dysfunction; 10.Those with combined neurological disorders; 11.Those with combined mental disorders; 12.Those who have changed their surgical methods; 13.Those who were transferred to the intensive care unit after the surgery; 14.Emergency operation; 15. Uncontrolled hypertension

Design outcomes

Primary

MeasureTime frame
The NRS score;

Secondary

MeasureTime frame
Sleep scores;Duration of indwelling of the drainage tube;The occurrence of depression;The number and function of NK cells, CD8+ T cells, CD4+ T cells, and the total number of lymphocytes;Chronic neuropathic pain;C-reactive protein;The dosage of propofol, remifentanil and vasoactive drugs used during the operation;Postoperative hospital stay;Remedy for pain relief situations;Is the acute pain trajectory an independent risk factor for the occurrence of chronic postoperative pain?;Incidence and severity score of postoperative nausea and vomiting;Whether pulmonary complications occurred after the surgery and the severity (grading) of these complications;NRS scores;Hemodynamic indicators;

Countries

China

Contacts

Public Contactzhangwei

Henan Provincial People's Hospita,medical

myhope2005@163.com+86 371 65580453

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026